Publications:

---

Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells

Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D

Publication Date: 2020-01-06

Variant appearance in text: ERK1: G186D

PubMed Link: 31935908

Variant Present in the following documents:

• Main text
• cells-09-00129.pdf

View BVdb publication page

---

Modulating multi-functional ERK complexes by covalent targeting of a recruitment site in vivo.

Nature Communications

Kaoud, Tamer S TS; Johnson, William H WH; Ebelt, Nancy D ND; Piserchio, Andrea A; Zamora-Olivares, Diana D; Van Ravenstein, Sabrina X SX; Pridgen, Jacey R JR; Edupuganti, Ramakrishna R; Sammons, Rachel R; Cano, Micael M; Warthaka, Mangalika M; Harger, Matthew M; Tavares, Clint D J CDJ; Park, Jihyun J; Radwan, Mohamed F MF; Ren, Pengyu P; Anslyn, Eric V EV; Tsai, Kenneth Y KY; Ghose, Ranajeet R; Dalby, Kevin N KN

Publication Date: 2019-11-19

Variant appearance in text: ERK1: G186D

PubMed Link: 31745079

Variant Present in the following documents:

• Main text
• 41467_2019_Article_12996.pdf

View BVdb publication page

---

Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer.

International Journal Of Molecular Sciences

Olea-Flores, Monserrat M; Zuñiga-Eulogio, Miriam Daniela MD; Mendoza-Catalán, Miguel Angel MA; Rodríguez-Ruiz, Hugo Alberto HA; Castañeda-Saucedo, Eduardo E; Ortuño-Pineda, Carlos C; Padilla-Benavides, Teresita T; Navarro-Tito, Napoleón N

Publication Date: 2019-06-13

Variant appearance in text: ERK1: Gly186Asp

PubMed Link: 31200510

Variant Present in the following documents:

• Main text
• ijms-20-02885.pdf

View BVdb publication page

---

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.

Cell Death & Disease

Grassi, Ludovica L; Alfonsi, Romina R; Francescangeli, Federica F; Signore, Michele M; De Angelis, Maria Laura ML; Addario, Antonio A; Costantini, Manuela M; Flex, Elisabetta E; Ciolfi, Andrea A; Pizzi, Simone S; Bruselles, Alessandro A; Pallocca, Matteo M; Simone, Giuseppe G; Haoui, Mustapha M; Falchi, Mario M; Milella, Michele M; Sentinelli, Steno S; Di Matteo, Paola P; Stellacci, Emilia E; Gallucci, Michele M; Muto, Giovanni G; Tartaglia, Marco M; De Maria, Ruggero R; Bonci, Désirée D

Publication Date: 2019-02-27

Variant appearance in text: ERK1: 557G>A

PubMed Link: 30814510

Variant Present in the following documents:

• 41419_2019_1453_MOESM27_ESM.xlsx, sheet 1

View BVdb publication page

---

Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants.

Cell Reports

Brenan, Lisa L; Andreev, Aleksandr A; Cohen, Ofir O; Pantel, Sasha S; Kamburov, Atanas A; Cacchiarelli, Davide D; Persky, Nicole S NS; Zhu, Cong C; Bagul, Mukta M; Goetz, Eva M EM; Burgin, Alex B AB; Garraway, Levi A LA; Getz, Gad G; Mikkelsen, Tarjei S TS; Piccioni, Federica F; Root, David E DE; Johannessen, Cory M CM

Publication Date: 2016-10-18

Variant appearance in text: MAPK3: G186D

PubMed Link: 27760319

Variant Present in the following documents:

• Main text

View BVdb publication page

---

ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

Cancer Research

Goetz, Eva M EM; Ghandi, Mahmoud M; Treacy, Daniel J DJ; Wagle, Nikhil N; Garraway, Levi A LA

Publication Date: 2014-12-01

Variant appearance in text: ERK1: G186D

PubMed Link: 25320010

Variant Present in the following documents:

• Main text

View BVdb publication page

---